Ascentage Pharma Group International (AAPG) Long-Term Investments (2023 - 2025)

Historic Long-Term Investments for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $4.6 million.

  • Ascentage Pharma Group International's Long-Term Investments changed N/A to $4.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is 8634.18% up from last year.
  • Ascentage Pharma Group International's Long-Term Investments amounted to $4.6 million in Q2 2025.
  • In the past 5 years, Ascentage Pharma Group International's Long-Term Investments registered a high of $4.6 million during Q2 2025, and its lowest value of $2.4 million during Q4 2023.
  • For the 3-year period, Ascentage Pharma Group International's Long-Term Investments averaged around $3.8 million, with its median value being $4.6 million (2024).
  • Over the last 5 years, Ascentage Pharma Group International's Long-Term Investments had its largest YoY gain of 9293.06% in 2024, and its largest YoY loss of 9293.06% in 2024.
  • Ascentage Pharma Group International's Long-Term Investments (Quarter) stood at $2.4 million in 2023, then skyrocketed by 92.93% to $4.6 million in 2024, then increased by 0.27% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q2 2025, $4.6 million for Q4 2024, and $2.4 million during Q4 2023.